Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332) - Hauke, J.; Ernst, C.; Fasching, Peter; Jackisch, C.; Seither, F.; Klare, P.; Rhiem, K. E.; Schmatloch, S.; Huober, J.; Stefek, A.; Seiler, S.; Uleer, C.; et al. (ANNALS OF ONCOLOGY, 2020)
CRIS-Team WoS Importer:2020-10-30